Article
Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study.
Genes and immunity - 1 Feb 2020
Bonomi Alice, Veglia Fabrizio, Baldassarre Damiano, Strawbridge Rona J, Golabkesh Zahra, Sennblad Bengt, Leander Karin, Smit Andries J, Giral Philippe, Humphries Steve E, Tremoli Elena, Hamsten Anders, de Faire Ulf, Gigante Bruna
Abstract excerpt
The genes regulating circulating levels of soluble gp130 (sgp130), the antagonist of the inflammatory response in atherosclerosis driven by interleukin 6, are largely unknown. Aims of the present study were to identify genetic loci associated with circulating sgp130 and to explore the potential association between variants associated with sgp130 and markers of subclinical atherosclerosis. The study is based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
